We are a growth company that has a clear strategy for growing our business. This strategy focus on expanding our license business, while developing new areas of use.
Through license and distribution agreements we are today present on many markets throughout the world. The USA and China represent our largest markets. We will grow on existing markets and enter new markets.
We currently have five license agreements and our goal is to have at least 10 application areas in license partnerships with products in the market by year-end 2028. Our technology is documented as being effective and safe and approved for longterm use in the human body, so we see the potential for new areas of applications and license business.